Insights from studies with oral cleft genes suggest associations between WNT-pathway genes and risk of oral cancer

Journal of Dental Research

Volumn 90, Issue 6, 2011, Pages 740-746

  Andrade Filho, P A ^a   Letra, A ^b   Cramer, A ^b   Prasad, J L ^b   Garlet, G P ^c   Vieira, A R ^b   Ferris, R L ^a   Menezes, R ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cleft lip palate; oral cancer; polymorphism; squamous cell carcinoma; WNT pathway genes

Indexed keywords

AXIN PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; REPRESSOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN; WNT PROTEIN; WNT11 PROTEIN, HUMAN; WNT3 PROTEIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; MALE; MIDDLE AGED; MOUTH TUMOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; FEMALE; GENE FREQUENCY; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 79956025444     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034511401622     Document Type: Article

References (26)

1. Andrade Filho PA, Ito D, Deleo AB, Ferris RL. CD8+ T cell recognition of polymorphic wild-type sequence p53 (65-73) peptides in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother. 2010 ; 59: 1561-1568
2. Bille C, Winther JF, Bautz A, Murray JC, Olsen J, Christensen K. Cancer risk in persons with oral cleft: a population-based study of 8,093 cases. Am J Epidemiol. 2005 ; 161: 1047-1055 (Pubitemid 40734353)
3. Chiquet BT, Blanton SH, Burt A, Ma D, Stal S, Mulliken JB, et al. Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet. 2008 ; 17: 2212-2218 (Pubitemid 351916577)
4. Christensen K, Juel K, Herskind AM, Murray JC. Long term follow up study of survival associated with cleft lip and palate at birth. BMJ. 2004 ; 328: 1405
5. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006 ; 127: 469-480
6. Garlet GP, Martins W, Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol. 2004 ; 31: 671-679 (Pubitemid 39092231)
7. Juriloff DM, Harris MJ, Dewell SL, Brown CJ, Mager DL, Gagnier L, et al. Investigations of the genomic region that contains the clf1 mutation, a causal gene in multifactorial cleft lip and palate in mice. Birth Defects Res A Clin Mol Teratol. 2005 ; 73: 103-113 (Pubitemid 40289534)
8. Juriloff DM, Harris MJ, McMahon AP, Carroll TJ, Lidral AC. Wnt9b is the mutated gene involved in multifactorial nonsyndromic cleft lip with or without cleft palate in A/WySn mice, as confirmed by a genetic complementation test. Birth Defects Res A Clin Mol Teratol. 2006 ; 76: 574-579 (Pubitemid 44465318)
9. Kim M, Datta A, Brakeman P, Yu W, Mostov KE. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis. J Cell Sci. 2007 ; 120 (Pt 14). 2309-2317 (Pubitemid 47225934)
10. Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004 ; 74: 1043-1050 (Pubitemid 38568974)
11. Lan Y, Ryan RC, Zhang Z, Bullard SA, Bush JO, Maltby KM, et al. Expression of Wnt9b and activation of canonical Wntsignaling during midfacial morphogenesis in mice. Dev Dyn. 2006 ; 235: 1448-1454 (Pubitemid 43843925)
12. Letra A, Menezes R, Granjeiro JM, Vieira AR. AXIN2 and CDH1 polymorphisms, tooth agenesis, and oral clefts. Birth Defects Res A Clin Mol Teratol. 2009 ; 85: 169-173
13. Liu F, Millar SE. Wnt/β-catenin signaling in oral tissue development and disease. J Dent Res. 2010 ; 89: 318-330
14. Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT. Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice. Nature. 2007 ; 446: 79-82 (Pubitemid 46348041)
15. Mani P, Jarrell A, Myers J, Atit R. Visualizing canonical Wnt signaling during mouse craniofacial development. Dev Dyn. 2010 ; 239: 354-363
16. Menezes R, Marazita ML, Goldstein McHenry T, Cooper ME, Bardi K, Brandon C, et al. Axis inhibition protein 2, orofacial clefts and a family history of cancer. J Am Dent Assoc. 2009 ; 140: 80-84
17. Menezes R, Letra A, Kim AH, Küchler EC, Day A, Tannure PN, et al. Studies with Wnt genes and nonsyndromic cleft lip and palate. Birth Defects Res A Clin Mol Teratol. 2010 ; 88: 995-1000
18. Mishra R. Glycogen synthase kinase 3 beta: can it be a target for oral cancer. Mol Cancer. 2010 ; 9: 144
19. Murray JC. Gene/environment causes of cleft lip and/or palate. Clin Genet. 2002 ; 61: 248-256 (Pubitemid 36372641)
20. National Institute of Dental and Craniofacial Research (2010). Oral cancer. URL available at: http://www.nidcr.nih.gov/OralHealth/Topics/OralCancer/ OralCancer.htm (accessed January 27, 2011).
21. Nishi M, Miyake H, Takeda T, Hatae Y. Congenital malformations and childhood cancer. Med Pediatr Oncol. 2000 ; 34: 250-254 (Pubitemid 30176600)
22. Notaridou M, Quaye L, Dafou D, Jones C, Song H, Hogdall E, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer. 2011 ;:
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007 ; 81: 559-575 (Pubitemid 47330214)
24. Toyama T, Lee HC, Koga H, Wands JR, Kim M. Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res. 2010 ; 8: 254-265
25. Tseng RC, Lin RK, Wen CK, Tseng C, Hsu HS, Hsu WH, et al. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type β-catenin nuclear accumulation in lung tumorigenesis. Oncogene. 2008 ; 27: 4488-4496
26. Zhu JL, Basso O, Hasle H, Winther JF, Olsen JH, Olsen J. Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark. Br J Cancer. 2002 ; 87: 524-528